Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: AlienTech who wrote (7641)	5/2/1998 1:50:00 PM
From: g.w. barnard	Read Replies (2) \| Respond to of 23519

at, your kidding of course. gw

To: AlienTech who wrote (7641)	5/3/1998 4:56:00 PM
From: OmertaSoldier	Read Replies (2) \| Respond to of 23519

AlienTech, Do you have ESP? You are close with that cancer perception!! TEST OF 'SINGLE MOST EXCITING' CANCER TREATMENT COMING New York Times News Service May 3, 1998 Within a year, if all goes well, the first cancer patient will be injected with two new drugs that can eradicate any type of cancer, with no obvious side effects and no drug resistance, so far only in mice. Some cancer researchers say the drugs are the most exciting treatment they have seen. Then they temper their enthusiasm with caution, noting that the history of cancer treatments is full of high expectations followed by dashed hopes when drugs with remarkable effects in animals are tested in people. Still, the National Cancer Institute has made the drugs their top priority, said Dr. Richard Klausner, institute director. Klausner called them "the single most exciting thing on the horizon" for the treatment of cancer. The drugs, angiostatin and endostatin, work by interfering with the blood supply tumors need. Given together, they make tumors disappear and not return. Dr. James Pluda, who is directing the cancer institute's planned tests of the drugs in patients, said he and others at the institute were "electrified" when they heard the drugs' discoverer deliver a lecture about the newest results. "People were almost overwhelmed," Pluda said. "The data were remarkable." Although the discovery of the drugs and some of their effects have been reported, Pluda said "if people understood how many steps ahead" the research was compared with what had been published, "they'd be even more in awe." Dr. Jerome Groopman, a cancer researcher at the Harvard Medical School, said, "We are all driven by hope, but a sober scientist waits for the data." Until the drugs are given to humans, he said, the crucial data simply do not exist. So far, the drugs are the only ones ever tested that can seemingly eradicate all tumors in mice, even gigantic ones equivalent to a two-pound growth in a human. The best that other cancer drugs have done is slow the growth of these large tumors. Mice are the traditional test animals in cancer research. Even the drugs' discoverer, Dr. Judah Folkman, a cancer researcher at Children's Hospital in Boston, is cautious about the drugs' promise. Until patients take them, he said, it is dangerous to make predictions. All he knows for sure, Folkman said, is that "if you have cancer and you are a mouse, we can take good care of you." P.S I deleted the company that was in the process of making this drug for everyone. GGGGG! Because who would want to invest in a drug like that? To small a market GGGG!